← Back to Search

Power + Interval Treadmill Training for Cerebral Palsy (PT³ Trial)

N/A

Waitlist Available

Led By Noelle G Moreau, PT, PhD

Research Sponsored by Louisiana State University Health Sciences Center in New Orleans

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of bilateral spastic Cerebral Palsy (CP)

GMFCS levels I, II, or III

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 2 months and 6 months post training

Awards & highlights

PT³ Trial Summary

This trial is studying the effect of lower extremity Power Training combined with interval Treadmill Training (PT³) on functional walking capacity and community-based activity and participation in children with cerebral palsy (CP).

Who is the study for?

This trial is for children aged 10-17 with bilateral spastic Cerebral Palsy, who can walk but have limitations. They should be classified as GMFCS levels I to III and not have had recent orthopedic or neurosurgery, nor injection therapies like botulinum toxin within the last few months.Check my eligibility

What is being tested?

The study tests a new approach combining muscle power training with interval treadmill exercises tailored for kids' walking patterns. It aims to improve their walking ability and daily life participation by focusing on developing lower extremity strength in a way that's appropriate for their developmental stage.See study design

What are the potential side effects?

While specific side effects are not listed, exercise programs may cause muscle soreness, fatigue, or discomfort initially. The intensity of these side effects typically decreases over time as the body adapts to the training regimen.

PT³ Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with bilateral spastic Cerebral Palsy.

Select...

I can walk with or without walking aids.

Select...

I am between 10 and 17 years old.

PT³ Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 2 months and 6 months post training

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 2 months and 6 months post training

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 2 months and 6 months post training for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Fast gait speed

Secondary outcome measures

Change in 1RM (muscle strength)

Change in Average strides per day

Change in Cross-sectional area

+7 more

PT³ Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: PT³Experimental Treatment1 Intervention

Power Training combined with interval treadmill training

Group II: Traditional trainingActive Control1 Intervention

Strength training combined with traditional treadmill training

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Power training combined with interval treadmill training

2019

N/A

~50

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH

1,967 Previous Clinical Trials

2,672,854 Total Patients Enrolled

29 Trials studying Cerebral Palsy

8,715 Patients Enrolled for Cerebral Palsy

University of WashingtonOTHER

1,743 Previous Clinical Trials

1,847,827 Total Patients Enrolled

10 Trials studying Cerebral Palsy

1,161 Patients Enrolled for Cerebral Palsy

Louisiana State University Health Sciences Center in New OrleansLead Sponsor

114 Previous Clinical Trials

44,158 Total Patients Enrolled

2 Trials studying Cerebral Palsy

84 Patients Enrolled for Cerebral Palsy

Media Library

Power Training Combined With Interval Treadmill Training Clinical Trial Eligibility Overview. Trial Name: NCT03625570 — N/A

Cerebral Palsy Research Study Groups: PT³, Traditional training

Cerebral Palsy Clinical Trial 2023: Power Training Combined With Interval Treadmill Training Highlights & Side Effects. Trial Name: NCT03625570 — N/A

Power Training Combined With Interval Treadmill Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT03625570 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible to become involved in this research undertaking?

"For this clinical trial, individuals with neurological ailments and between the ages of 10-17 are eligible. A total of 48 participants need to be recruited."

Answered by AI

Does your research include participants aged below 70 years?

"This trial is exclusively for minors aged 10 to 17, with a total of 213 trials open to those under 18 and 351 available for adults over 65."

Answered by AI

How many participants are being recruited for this clinical investigation?

"Correct. According to clinicaltrials.gov, the specified trial is currently recruiting patients and 48 participants need to be sourced across two sites. It was first posted on April 15th 2019 and its most recent edit took place on April 28th 2021."

Answered by AI

Are there any vacancies in this clinical experiment for participants?

"As indicated on clinicaltrials.gov, this medical study is actively seeking participants. The trial was published in April of 2019 and the most recent update took place on the 28th of 2021."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Power Training Combined With Interval Treadmill Training

2019. "Power Training Combined With Interval Treadmill Training". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03625570.